{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:35:10Z","timestamp":1787009710220,"version":"build-2736575974"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To describe the clinico-laboratory profile, intensive care needs and outcome of multisystem inflammatory syndrome in children (MIS-C) during the first and second waves.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>This retrospective study was conducted in the paediatric emergency and paediatric intensive care unit (PICU) of a tertiary care teaching hospital in North India involving 122 children with MIS-C admitted during the first wave (September 2020\u2013January 2021, n\u2009=\u200940) and second wave (February 2021\u2013September 2021, n\u2009=\u200982) of coronavirus disease 2019 (COVID-19).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median (interquartile range) age was 7 (4\u201310) years and 67% were boys. Common manifestations included fever (99%), abdominal symptoms (81%), rash (66%) and conjunctival injection (65%). Elevated C-reactive protein (97%), D-dimer (89%), procalcitonin (80%), IL-6 (78%), ferritin (56%), N-terminal pro B-type natriuretic peptide (84%) and positive severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibody (81%) were common laboratory abnormalities. Cardiovascular manifestations included myocardial dysfunction (55%), shock (48%) and coronary artery changes (10%). The treatment included intensive care support (57%), non-invasive (33%) and invasive (18%) ventilation, vasoactive drugs (47%), intravenous immunoglobulin (IVIG) (83%), steroids (85%) and aspirin (87%). The mortality was 5% (n\u2009=\u20096). During the second wave, a significantly higher proportion had positive SARS-CoV-2 antibody, contact with COVID-19 and oral mucosal changes; lower markers of inflammation; lower proportion had lymphopenia, elevated IL-6 and ferritin; lower rates of shock, myocardial dysfunction and coronary artery changes; lesser need of PICU admission, fluid boluses, vasoactive drugs and IVIG; and shorter hospital stay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MIS-C is a febrile multisystemic disease characterized by hyperinflammation, cardiovascular involvement, temporal relationship to SARS-CoV-2 and good outcome with immunomodulation and intensive care. During the second wave, the severity of illness, degree of inflammation, intensive care needs, and requirement of immunomodulation were less as compared to the first wave.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/tropej\/fmac068","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T09:56:15Z","timestamp":1661334975000},"source":"Crossref","is-referenced-by-count":7,"title":["Clinico-Laboratory Profile, Intensive Care Needs and Short-Term Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience during First and Second Waves from North India"],"prefix":"10.1093","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6370-8258","authenticated-orcid":false,"given":"Suresh Kumar","family":"Angurana","sequence":"first","affiliation":[{"name":"Division of Pediatric Emergency and Intensive Care, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh 160012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kumar","sequence":"additional","affiliation":[{"name":"Division of Pediatric Emergency and Intensive Care, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh 160012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthi","family":"Nallasamy","sequence":"additional","affiliation":[{"name":"Division of Pediatric Emergency and Intensive Care, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh 160012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj Rohit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh 160012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Naganur","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh 160012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Immunopathology, Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh 160012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Goyal","sequence":"additional","affiliation":[{"name":"Department of Virology, Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh 160012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnab","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Department of Virology, Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh 160012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Bansal","sequence":"additional","affiliation":[{"name":"Division of Pediatric Emergency and Intensive Care, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh 160012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muralidharan","family":"Jayashree","sequence":"additional","affiliation":[{"name":"Division of Pediatric Emergency and Intensive Care, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh 160012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"key":"2022090114401608700_fmac068-B1","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jama.2021.2091","article-title":"Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19","volume":"325","author":"Feldstein","year":"2021","journal-title":"JAMA"},{"key":"2022090114401608700_fmac068-B2","doi-asserted-by":"crossref","first-page":"fmab055","DOI":"10.1093\/tropej\/fmab055","article-title":"Intensive care needs and short-term outcome of multisystem inflammatory syndrome in children (MIS-C): experience from North India","volume":"67","author":"Angurana","year":"2021","journal-title":"J Trop Pediatr"},{"key":"2022090114401608700_fmac068-B3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jamapediatrics.2021.0630","article-title":"Trends in geographic and temporal distribution of US children with multisystem inflammatory syndrome during the COVID-19 pandemic","volume":"175","author":"Belay","year":"2021","journal-title":"JAMA Pediatr"},{"key":"2022090114401608700_fmac068-B4","first-page":"1","article-title":"Clinicolaboratory profile, treatment, intensive care needs, and outcome of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2: a systematic review and meta-analysis","volume":"11","author":"Williams","year":"2020","journal-title":"J Pediatr Intensive Care"},{"key":"2022090114401608700_fmac068-B5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/PCC.0000000000002897","article-title":"Multisystem inflammatory syndrome in children: host immunologic responses","volume":"23","author":"Mazer","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"2022090114401608700_fmac068-B6","doi-asserted-by":"crossref","first-page":"fmab071","DOI":"10.1093\/tropej\/fmab071","article-title":"Updated management protocol for multisystem inflammatory syndrome in children (MIS-C)","volume":"67","author":"Takia","year":"2021","journal-title":"J Trop Pediatr"},{"key":"2022090114401608700_fmac068-B7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa2102605","article-title":"Multisystem inflammatory syndrome in children\u2014initial therapy and outcomes","volume":"385","author":"Son","year":"2021","journal-title":"N Engl J Med"},{"key":"2022090114401608700_fmac068-B8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa2102968","article-title":"Treatment of multisystem inflammatory syndrome in children","volume":"385","author":"McArdle","year":"2021","journal-title":"N Engl J Med"},{"key":"2022090114401608700_fmac068-B9","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1002\/art.41616","article-title":"American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 2","volume":"73","author":"Henderson","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2022090114401608700_fmac068-B10","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1097\/PCC.0000000000002728","article-title":"Association between treatments and short-term biochemical improvements and clinical outcomes in post-severe acute respiratory syndrome coronavirus-2 inflammatory syndrome","volume":"22","author":"Davies","year":"2021","journal-title":"Pediatr Crit Care Med"},{"key":"2022090114401608700_fmac068-B11","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet"},{"key":"2022090114401608700_fmac068-B12","doi-asserted-by":"crossref","article-title":"Multisystem inflammatory syndrome in children\u2014United States, February 2020-July 2021","author":"Miller","DOI":"10.1093\/cid\/ciab1007"},{"key":"2022090114401608700_fmac068-B13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jped.2021.08.006","article-title":"Multisystem inflammatory syndrome (MIS-C): a systematic review and meta-analysis of clinical characteristics, treatment, and outcomes","volume":"98","author":"Santos","year":"2022","journal-title":"J Pediatr (Rio J)"},{"key":"2022090114401608700_fmac068-B14","doi-asserted-by":"crossref","first-page":"e2116420","DOI":"10.1001\/jamanetworkopen.2021.16420","article-title":"Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS-CoV-2","volume":"4","author":"Payne","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2022090114401608700_fmac068-B15","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.15585\/mmwr.mm6932e2","article-title":"COVID-19-Associated multisystem inflammatory syndrome in children\u2014United States, March-July 2020","volume":"69","author":"Godfred-Cato","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022090114401608700_fmac068-B16","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.1097\/INF.0000000000003260","article-title":"Recent experience: corticosteroids as a first-line therapy in children with multisystem inflammatory syndrome and COVID-19-related myocardial damage","volume":"40","author":"Vukomanovic","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"2022090114401608700_fmac068-B17","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1161\/CIRCULATIONAHA.120.050147","article-title":"Addition of corticosteroids to immunoglobulins is associated with recovery of cardiac function in multi-inflammatory syndrome in children","volume":"142","author":"Belhadjer","year":"2020","journal-title":"Circulation"},{"key":"2022090114401608700_fmac068-B18","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jama.2021.0694","article-title":"Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children","volume":"325","author":"Ouldali","year":"2021","journal-title":"JAMA"},{"key":"2022090114401608700_fmac068-B19","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1097\/PCC.0000000000002598","article-title":"Multisystem inflammatory syndrome in children associated with coronavirus disease 2019 in a Children\u2019s Hospital in New York City: patient characteristics and an institutional protocol for evaluation, management, and follow-up","volume":"22","author":"Jonat","year":"2021","journal-title":"Pediatr Crit Care Med"},{"key":"2022090114401608700_fmac068-B20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. children and adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N Engl J Med"},{"key":"2022090114401608700_fmac068-B21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S2352-4642(20)30215-7","article-title":"Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study","volume":"4","author":"Davies","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"2022090114401608700_fmac068-B22","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s13312-020-2025-1","article-title":"Epidemiological and clinical profile of pediatric inflammatory multisystem syndrome\u2014temporally associated with SARS-CoV-2 (PIMS-TS) in Indian children","volume":"57","author":"Dhanalakshmi","year":"2020","journal-title":"Indian Pediatr"},{"key":"2022090114401608700_fmac068-B23","doi-asserted-by":"crossref","first-page":"fmaa127","DOI":"10.1093\/tropej\/fmaa127","article-title":"Unusual clinical manifestations and outcome of multisystem inflammatory syndrome in children (MIS-C) in a tertiary care hospital of North India","volume":"67","author":"Gupta","year":"2021","journal-title":"J Trop Pediatr"},{"key":"2022090114401608700_fmac068-B24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12098-021-03996-y","article-title":"Epididymo-orchitis: a rare manifestation of MIS-C","volume":"89","author":"Sudeep","year":"2022","journal-title":"Indian J Pediatr"},{"key":"2022090114401608700_fmac068-B25","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1097\/INF.0000000000003181","article-title":"Acral gangrene: ugly cousin of \u201cCOVID Toes\u201d in multisystem inflammatory syndrome in children associated with SARS-CoV-2?","volume":"40","author":"Chaudhary","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"2022090114401608700_fmac068-B26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12098-021-03773-x","article-title":"Hemorrhagic nonpurulent conjunctivitis in MIS-C","volume":"89","author":"Angurana","year":"2022","journal-title":"Indian J Pediatr"},{"key":"2022090114401608700_fmac068-B27","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1148\/radiol.2020202543","article-title":"Spectrum of imaging findings on chest radiographs, US, CT, and MRI images in multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19","volume":"298","author":"Hameed","year":"2021","journal-title":"Radiology"},{"key":"2022090114401608700_fmac068-B28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jama.2020.10369","article-title":"Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2","volume":"324","author":"Whittaker","year":"2020","journal-title":"JAMA"},{"key":"2022090114401608700_fmac068-B29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12098-021-04019-6","article-title":"MIS-C mimickers: a case series of bacterial enteritis and sepsis mistaken as MIS-C","volume":"89","author":"K","year":"2022","journal-title":"Indian J Pediatr"},{"key":"2022090114401608700_fmac068-B30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/CIRCULATIONAHA.120.048360","article-title":"Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic","volume":"142","author":"Belhadjer","year":"2020","journal-title":"Circulation"},{"key":"2022090114401608700_fmac068-B31","first-page":"69","article-title":"Multi-system inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management","volume":"7","author":"Nakra","year":"2020","journal-title":"Children (Basel)"},{"key":"2022090114401608700_fmac068-B32","first-page":"2001010","article-title":"SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France","volume":"25","author":"Belot","year":"2020","journal-title":"Euro Surveill"},{"key":"2022090114401608700_fmac068-B33","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1097\/INF.0000000000002888","article-title":"A systematic review of multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection","volume":"39","author":"Kaushik","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"2022090114401608700_fmac068-B34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40124-021-00259-4","article-title":"Treatment of MIS-C in children and adolescents","volume":"10","author":"Mahmoud","year":"2022","journal-title":"Curr Pediatr Rep"},{"key":"2022090114401608700_fmac068-B35","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1097\/PCC.0000000000002598","article-title":"Multisystem inflammatory syndrome in children associated with coronavirus disease 2019 in a Children\u2019s Hospital in New York City: patient characteristics and an institutional protocol for evaluation, management, and follow-up","volume":"22","author":"Jonat","year":"2021","journal-title":"Pediatr Crit Care Med"},{"key":"2022090114401608700_fmac068-B36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S2352-4642(20)30304-7","article-title":"A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process","volume":"5","author":"Harwood","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"2022090114401608700_fmac068-B37","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamapediatrics.2021.2993","article-title":"One-year outcomes of critical care patients post-COVID-19 multisystem inflammatory syndrome in children","volume":"175","author":"Davies","year":"2021","journal-title":"JAMA Pediatr"},{"key":"2022090114401608700_fmac068-B38","doi-asserted-by":"crossref","first-page":"e2021051155","DOI":"10.1542\/peds.2021-051155","article-title":"Longitudinal outcomes for multisystem inflammatory syndrome in children","volume":"148","author":"Farooqi","year":"2021","journal-title":"Pediatrics"},{"key":"2022090114401608700_fmac068-B39","doi-asserted-by":"crossref","first-page":"ofab388","DOI":"10.1093\/ofid\/ofab388","article-title":"Demographic and clinical factors associated with death among persons &lt;21 years old with multisystem inflammatory syndrome in children-United States","volume":"8","author":"Bowen","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2022090114401608700_fmac068-B40","doi-asserted-by":"crossref","first-page":"751","DOI":"10.4269\/ajtmh.21-0586","article-title":"Impact of recent SARS-CoV-2 infection on the course and severity of dengue in children: a prospective observational study from North India","volume":"105","author":"Ravikumar","year":"2021","journal-title":"Am J Trop Med Hyg"}],"container-title":["Journal of Tropical Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/tropej\/article-pdf\/68\/5\/fmac068\/45641203\/fmac068.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/tropej\/article-pdf\/68\/5\/fmac068\/45641203\/fmac068.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T11:14:40Z","timestamp":1662030880000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/tropej\/article\/doi\/10.1093\/tropej\/fmac068\/6680455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,8,4]]}},"URL":"https:\/\/doi.org\/10.1093\/tropej\/fmac068","relation":{},"ISSN":["0142-6338","1465-3664"],"issn-type":[{"value":"0142-6338","type":"print"},{"value":"1465-3664","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,1]]},"published":{"date-parts":[[2022,8,4]]},"article-number":"fmac068"}}